TogetHER for Health (TogetHER) has joined forces with the Communication for Development and Advocacy Consult (CDA Consult) to ...

A new trial finds that cetuximab outperforms durvalumab as a second-line treatment in patients who cannot tolerate cisplatin.

Vaccination of 27- to 45-year-olds against HPV is less cost-effective than vaccination of younger persons (aged 9 to 26 years).

Dr. Carrie Sopata, a gynecologist at UVA Health, said women can opt for the new procedure to avoid a speculum exam.

The statistics are alarming. Every two minutes, a woman dies of cervical cancer in countries where access to public health, ...

Cervical cancer deaths have plunged dramatically among women under age 25, and researchers at MUSC Hollings Cancer Center ...

Researchers observed a “steep decline” in cervical cancer deaths between 2016 and 2021 among US women younger than 25 years of age.

Robert F. Kennedy Jr., President-elect Donald Trump’s pick to oversee the nation’s health system, worries the medical ...

Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight ...

On Monday, a record number of women will be sworn in to the California state Legislature. I'm 72 years old, healthy, retired ...

Bolivia has taken a critical step towards strengthening its cancer control system by hosting an imPACT Review mission led by ...

“We observed a … 62% drop in cervical cancer deaths over the last decade, likely due to HPV vaccination,” said study senior ...